Cannassure Therapeutics Ltd (CSURE.TA)

TLV Healthcare Biotechnology

Cannassure Therapeutics Ltd operates in the Biotechnology industry of the Healthcare sector. The stock last traded at $43.20, up 1.65% on the session, giving a market capitalisation of $22.1M. Its beta of 0.00 implies it has historically moved less than the broad market.

Cannassure Therapeutics Ltd specializes in the cultivation and production of medical cannabis. Its diverse product portfolio features medical cannabis oils, a range of inflorescences including indoor, select, and value varieties, and cannavix. The company, established in 2016, is headquartered in Ashdod, Israel.

Cannassure Therapeutics Ltd is most often compared with the following Healthcare names: